(Reuters) — Unilife Corp (UNIS.O), which makes injections and insulin patch pumps, said on Wednesday it had hired Morgan Stanley to help it review strategic alternatives, including a sale, after getting interest from a possible buyer.
The company received a “third-party initiated expressions of interest”, it said in a statement, without giving further details.
Unilife also said it is evaluating the possibility of a strategic partnership and licensing some of its technology.
Trading in the company’s stock was halted before U.S. markets opened.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.